Mari McQuitty
Impact in
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- HIV/AIDS Research and Interventions 5
-
- HIV, Drug Use, Sexual Risk 5
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Claire Harrison (5 shared papers)Viktoriya Stalbovskaya (5 shared papers)Haifa Kathrin Al‐Ali (5 shared papers)Heinz Gisslinger (4 shared papers)Tiziano Barbui (4 shared papers)Alessandro M. Vannucchi (3 shared papers)Francisco Cervantes (3 shared papers)Jean‐Jacques Kiladjian (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)Journal of Clinical Oncology (1 paper)Leukemia (1 paper)Blood Pressure (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Mari McQuitty
15 papers receiving 2.2k citations
Mari McQuitty's Hit Papers
Peers
Comparison fields: 5 of 83
- Genetics 1.7k
- Hematology 1.1k
- Rheumatology 519
- Molecular Biology 846
- Oncology 196
Countries citing papers authored by Mari McQuitty
This map shows the geographic impact of Mari McQuitty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari McQuitty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari McQuitty more than expected).
Fields of papers citing papers by Mari McQuitty
This network shows the impact of papers produced by Mari McQuitty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari McQuitty. The network helps show where Mari McQuitty may publish in the future.
Co-authors
The 25 scholars most cited alongside Mari McQuitty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Hit paper breakdown → | 2012 | 1244 |
| 2 | Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis Hit paper breakdown → | 2016 | 357 |
| 3 | 2013 | 299 | |
| 4 | 1997 | 90 | |
| 5 | 2002 | 56 | |
| 6 | 2015 | 35 | |
| 7 | 2000 | 26 | |
| 8 | 2011 | 22 | |
| 9 | 2000 | 21 | |
| 10 | 2003 | 21 | |
| 11 | 2001 | 12 | |
| 12 | 1999 | 10 | |
| 13 | 1999 | 3 | |
| 14 | 2001 | 3 | |
| 15 | 2002 | 2 | |
| 16 | 2006 | 0 |
About Mari McQuitty
Mari McQuitty is a scholar working on Infectious Diseases, Epidemiology, Genetics, Sociology and Political Science and Surgery, having authored 16 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), HIV, Drug Use, Sexual Risk (5 papers), Sex work and related issues (3 papers), Epilepsy research and treatment (2 papers), Kruppel-like factors research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Genetics (1.7k citations), Hematology (1.1k citations), Rheumatology (519 citations), Molecular Biology (846 citations) and Oncology (196 citations). Mari McQuitty has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Claire Harrison, Viktoriya Stalbovskaya, Haifa Kathrin Al‐Ali, Heinz Gisslinger, Tiziano Barbui, Alessandro M. Vannucchi, Francisco Cervantes, Jean‐Jacques Kiladjian, Giovanni Barosi and Deborah Hunter. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Clinical Oncology, Leukemia and Blood Pressure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.